【24h】

Irradiated homologous rib grafts in nasal reconstruction.

机译:辐照同源肋骨移植鼻重建。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess the long-term efficacy of irradiated homologous rib grafts (IHRGs) for both augmentation and support function in rhinoplasty in general and for specific recipient sites within the nose. DESIGN: A retrospective study was conducted at an academic medical center to evaluate the loss of volume and support function of IHRGs in 9 specific recipient sites in the nose. RESULTS: We studied 66 patients, with a total of 177 IHRGs, dating back 9 years, with an average follow-up of 51 months. The rate of resorption increased with duration of follow-up. Complete resorption was found in 1 IHRG, and moderate resorption was observed in 55 IHRGs (31%). Resorption was characterized by a loss of support function rather than a loss of volume. Moderate resorption had a negative clinical outcome for shield grafts only. CONCLUSIONS: Irradiated homologous rib grafts were safe to use in rhinoplasty. In cases requiring a shield graft, IHRGs should be avoided.
机译:目的:评估的长期疗效辐照同源肋骨移植(IHRGs)鼻整形术的增强和支持功能一般和特定收件人的网站在鼻子上。进行学术医学中心评估损失的体积和支持功能的IHRGs 9中的特定收件人网站鼻子。177 IHRGs, 9年前,平均随访51个月。吸收增加,后续的持续时间。完成吸收被发现在1 IHRG,适度的吸收在55 IHRGs(31%)。支持函数而不是体积的损失。适度的吸收-临床结果仅供盾移植。辐照同源肋骨移植是安全的使用在鼻整形术。贪污,IHRGs应该避免。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号